Ian Frank Scholes
Chief Executive Officer at Chord Capital Pty Ltd.
Net worth: 488 497 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Condella | M | 70 | 6 years | |
| Patrick Blake | M | 59 | 6 years | |
| Gerald Allan Bullon | M | 77 | 11 years | |
| Geoffrey MacDonald Knight | M | 78 | 11 years | |
| Bruce Robinson | M | 67 | 10 years | |
| Laura Loftus | F | - | 4 years | |
| Hemanshu N. Pandya | M | 52 | 3 years | |
| Brant Schofield | M | - | 6 years | |
| Kathryn MacFarlane | M | 58 | 2 years | |
| Keith Moore | M | - | 9 years | |
| Ann Custin | F | 64 | 2 years | |
| Aaron Gray | M | - | 2 years | |
| David Petrie | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roger Aston | M | 68 |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 7 years |
| Craig Bottomley | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Aaron John Finlay | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Roger Corbett | M | 81 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Ron Best | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 13 years |
| Stuart Mudge | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Nancy Dolan | F | 72 | 6 years | |
| Jeffrey Robert Paterson | M | 76 | 1 years | |
| Nicholas Freeman | M | - | 3 years | |
| Angelo Morella | M | - | - | |
| Scott Richards | M | 60 | 10 years | |
| Mark Cansdale | M | - | 6 years | |
| William Hodges | M | 67 | 6 years | |
| Peter Paltoglou | M | - | 7 years | |
| Danny Dragovic | M | - | - | |
| Andrew van Breugel | M | - | 2 years | |
| Craig Boyd | M | - | - | |
| Gadi Ben Nissim | M | - | 1 years | |
| Carolyn Myers | M | 66 | 2 years | |
| Ilana Stancovski | M | - | - | |
| Kate Hall | F | - | - | |
| Stefan J. Cross | M | 51 | 11 years | |
| Peter James Truelove | M | - | - | |
| Gina Greentree | F | - | 1 years | |
| Simone Parkes | F | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Bruce Mathieson | M | 80 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 3 years |
| Kimberly McClintock | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 40 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ian Frank Scholes
- Personal Network
